TY - JOUR
T1 - Effect of violet light-transmitting eyeglasses on axial elongation in myopic children
T2 - A randomized controlled trial
AU - Mori, Kiwako
AU - Torii, Hidemasa
AU - Hara, Yutaka
AU - Hara, Michiko
AU - Yotsukura, Erisa
AU - Hanyuda, Akiko
AU - Negishi, Kazuno
AU - Kurihara, Toshihide
AU - Tsubota, Kazuo
N1 - Funding Information:
The current study was financially supported from JINS HOLDINGS, Inc.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/11/1
Y1 - 2021/11/1
N2 - The fact that outdoor light environment is an important suppressive factor against myopia led us to invent violet light-transmitting eyeglasses (VL glasses) which can transmit violet light (VL), 360–400 nm in wavelength, for the suppression of myopia, and can meanwhile block harmful ultra-violet waves from sunlight. The current study is a double-blinded randomized clinical trial to investigate the myopia-suppressive effect of VL glasses compared to conventional eyeglasses (placebo glasses) that do not transmit VL. The subjects were children aged from 6 to 12 years old, the population in which myopia progression is generally accelerated, and the myopia suppressive effect was followed up for two years in a city in Japan. Periodical ophthalmic examinations, interviews, and measurements of reflection and axial length under mydriasis were performed at the initial visit (the baseline) and at 1, 6, 12, 18, and 24 months. The mean change in axial length in the VL glasses group was significantly smaller than in the placebo glasses group when time for near-work was less than 180 min and when the subjects were limited to those who had never used eyeglasses before this trial (p < 0.01); however, this change was not significant without subgrouping. The suppressive rate for axial elongation in the VL glasses group was 21.4% for two years.
AB - The fact that outdoor light environment is an important suppressive factor against myopia led us to invent violet light-transmitting eyeglasses (VL glasses) which can transmit violet light (VL), 360–400 nm in wavelength, for the suppression of myopia, and can meanwhile block harmful ultra-violet waves from sunlight. The current study is a double-blinded randomized clinical trial to investigate the myopia-suppressive effect of VL glasses compared to conventional eyeglasses (placebo glasses) that do not transmit VL. The subjects were children aged from 6 to 12 years old, the population in which myopia progression is generally accelerated, and the myopia suppressive effect was followed up for two years in a city in Japan. Periodical ophthalmic examinations, interviews, and measurements of reflection and axial length under mydriasis were performed at the initial visit (the baseline) and at 1, 6, 12, 18, and 24 months. The mean change in axial length in the VL glasses group was significantly smaller than in the placebo glasses group when time for near-work was less than 180 min and when the subjects were limited to those who had never used eyeglasses before this trial (p < 0.01); however, this change was not significant without subgrouping. The suppressive rate for axial elongation in the VL glasses group was 21.4% for two years.
KW - Axial length
KW - Double blinded randomized controlled trial
KW - Eyeglasses
KW - Myopia
KW - Myopia control
KW - Refraction
KW - Violet light
UR - http://www.scopus.com/inward/record.url?scp=85119414800&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85119414800&partnerID=8YFLogxK
U2 - 10.3390/jcm10225462
DO - 10.3390/jcm10225462
M3 - Article
AN - SCOPUS:85119414800
SN - 2077-0383
VL - 10
JO - Journal of Clinical Medicine
JF - Journal of Clinical Medicine
IS - 22
M1 - 5462
ER -